118.59
31-十月-24 15:59:59
15 分钟延时
股票
-1.44
-1.20%
今日范围
117.51 - 120.14
ISIN
N/A
来源
NYSE
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection
18 5月 2021 09:15:00 条件 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency
11 5月 2021 09:15:00 条件 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
29 4月 2021 09:15:00 条件 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
27 4月 2021 09:15:00 条件 Nasdaq GlobeNewswire